Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhenfei Bi
Correction: PAMs Ameliorates the Imiquimod-Induced Psoriasis-Like Skin Disease in Mice by Inhibition of Translocation of NF-κB and Production of Inflammatory Cytokines
PLoS ONE
Multidisciplinary
PAMs Ameliorates the Imiquimod-Induced Psoriasis-Like Skin Disease in Mice by Inhibition of Translocation of NF-κB and Production of Inflammatory Cytokines
PLoS ONE
Multidisciplinary
Related publications
Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice
PLoS ONE
Multidisciplinary
061 Dextran-Based Mycophenolic Acid Nanoparticle Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
710 Tussilagonone Ameliorates Psoriatic Features in an Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
1043 Systemic Delivery of HMGB1 Peptide Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Blocking mTOR Signalling With Rapamycin Ameliorates Imiquimod-Induced Psoriasis in Mice
Acta Dermato-Venereologica
Dermatology
Medicine
459 HOIPIN-1, a Novel LUBAC Inhibitor, Suppresses the Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Fn14 Deficiency Ameliorates Psoriasis-Like Skin Disease in a Murine Model
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs
PLoS ONE
Multidisciplinary
